Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Beam Therapeutics (BEAM) Profit After Tax: 2019-2024

Historic Profit After Tax for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to -$376.7 million.

  • Beam Therapeutics' Profit After Tax fell 16.61% to -$112.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$414.6 million, marking a year-over-year decrease of 188.77%. This contributed to the annual value of -$376.7 million for FY2024, which is 184.28% down from last year.
  • As of FY2024, Beam Therapeutics' Profit After Tax stood at -$376.7 million, which was down 184.28% from -$132.5 million recorded in FY2023.
  • Over the past 5 years, Beam Therapeutics' Profit After Tax peaked at -$132.5 million during FY2023, and registered a low of -$376.7 million during FY2024.
  • For the 3-year period, Beam Therapeutics' Profit After Tax averaged around -$266.1 million, with its median value being -$289.1 million (2022).
  • Its Profit After Tax has fluctuated over the past 5 years, first soared by 54.16% in 2023, then plummeted by 184.28% in 2024.
  • Yearly analysis of 5 years shows Beam Therapeutics' Profit After Tax stood at -$194.6 million in 2020, then tumbled by 90.47% to -$370.6 million in 2021, then climbed by 22.00% to -$289.1 million in 2022, then skyrocketed by 54.16% to -$132.5 million in 2023, then crashed by 184.28% to -$376.7 million in 2024.